Patients with myofasical pain of the trapezius Myofascial pain, Peripheral magnetic stimulation, Thai traditional massage, Quality of life, Cost effectiveness
Conditions
Interventions
Participants will receive repetitive Peripheral Magnetic Stimulation (rPMS) treatment twice weekly for 3 weeks (total 6 sessions, 20 minutes each). A Salus Talent Pro rPMS device with a circular coil
s muscle characteristics.
During the procedure, the identification code the practitioner will be recorded in the participant'
s record form. Adverse events such as increased pain, numbness, or dizziness will be monitored and recorded. The treatment will stop immediately if participant experiences faintin
Repetitive Peripheral Magnetic Stimulation,Thai traditional massage
Sponsors
Papob Chaiwatanodom, M.D.
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Age 18 years or older 2. Pain of one side of the trapezius for at least 3 months prior to study 3. Diagnosed with myofascial pain syndrome according to Simons' criteria 4. Visual analogue scale (VAS) score for spontaneous pain of the trapezius ranging between 3 and 6 5. Deny any treatment with physical therapy equipments or Thai traditional massage for at least 3 months prior to study
Exclusion criteria
Exclusion criteria: 1. Presence of electrical implants in the body, such as a cardiac pacemaker, deep brain stimulator, or cochlear implant 2. Presence of metallic implants in the treatment area, such as a mechanical heart valve or metal rods used for bone fixation after surgery 3. Pregnant women 4. History of cervical radiculopathy, cervical myelopathy, cervical spinal stenosis, or fibromyalgia 5. History of spinal fracture at least 6 months prior to the study 6. Underlying conditions that contraindicate the procedure, including history of epilepsy, cancer at the treatment site, or history of advanced/metastatic cancer 7. History of coagulopathy, including platelet count less than 50,000 per microliter, INR more than 3.0, or use of anticoagulant medication with abnormal bleeding 8. Open wounds or infection at the treatment site 9. Contagious skin diseases transmissible through contact, such as tinea, herpes zoster, or scabies
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effectiveness in pain reduction baseline, immediately after treatment, 1 month and 3 months after treatment Visual Analogue Scale ,Cost effectiveness baseline, immediately after treatment, 1 month and 3 months after treatment EuroQol 5Dimension 5Level Questionnaire to calculate Quality-adjusted life years (QALYs) | — |
Secondary
| Measure | Time frame |
|---|---|
| Effectiveness in pain reduction baseline, immediately after treatment, 1 month and 3 months after treatment Pain pressure threshold using a digital algometer,Cervical mobility baseline, immediately after treatment, 1 month and 3 months after treatment Cervical range of motion including flexion, extension, lateral flexion, and rotation using the goniometer device,Neck disability baseline, immediately after treatment, 1 month and 3 months after treatment Neck disability index | — |
Countries
Thailand
Contacts
Public ContactPanjarat Lewsriskul
Department of Rehabilitation Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University
Outcome results
None listed